Veerhealth Care

{
  "main_header": {
    "sid": 631680,
    "name": "Veerhealth Care",
    "stock_name": "Veerhealth Care",
    "full_name": "Veerhealth Care Ltd",
    "name_url": "stocks-analysis/veerhealth-care",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "20.00",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 511523,
    "symbol": "NIYATILEAS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE882C01035",
    "curr_date": "Mar 19",
    "curr_time": "",
    "bse_nse_vol": "1.08 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 19, 2026",
    "traded_date_str": "2026 03 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/veerhealth-care-631680-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Veerhealth Care Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-ltd-is-rated-sell-3900093",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VeerhealthCareL_mojoScore_3900093.png",
        "date": "2026-03-19 10:10:49",
        "description": "Veerhealth Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Veerhealth Care Ltd’s Mixed Week: -0.61% Price, Outperformance vs Sensex",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/veerhealth-care-ltds-mixed-week--061-price-outperformance-vs-sensex-3862540",
        "imagepath": "",
        "date": "2026-02-28 15:07:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Feb 2026:</strong> Stock rises 0.81% to Rs.19.98, outperforming Sensex</p>\n                    <p><strong>25 Feb 2026:</strong> Death Cross formation signals potential bearish trend</p>\n                    <p><strong>26 Feb 2026:</strong> Mojo Grade downgraded to Sell amid mixed signals</p>\n                    <p><strong>27 Feb 2026:</strong> Stock closes week at Rs.19.70, down 1.35% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.19.82</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..."
      },
      {
        "title": "Veerhealth Care Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3857414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VeerhealthCareL_mojoScore_3857414.png",
        "date": "2026-02-26 08:08:27",
        "description": "Veerhealth Care Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 February 2026. This shift reflects a complex interplay of factors across quality, valuation, financial trends, and technical indicators, despite the company’s recent positive quarterly performance and strong stock returns relative to benchmarks."
      },
      {
        "title": "Veerhealth Care Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/veerhealth-care-ltd-forms-death-cross-signalling-potential-bearish-trend-3855990",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VeerhealthCareL_dealthcross_3855990.png",
        "date": "2026-02-25 18:50:16",
        "description": "Veerhealth Care Ltd (Stock ID: 631680) has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s near-term momentum and long-term strength within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Veerhealth Care Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-veerhealth-care-ltd-fallingrising-3851853",
        "imagepath": "",
        "date": "2026-02-24 01:11:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Consistent Outperformance Against Benchmarks</strong></p>\n<p>Veerhealth Care Ltd has demonstrated remarkable strength relative to the broader market, as evidenced by its performance compared to the Sensex. Over the past week, the stock surged by 5.55%, significantly outpacing the Sensex’s marginal gain of 0.02%. This trend extends over longer periods, with the stock delivering a 12.25% return in the last month against the Sensex’s 2.15%. Year-to-date, Veerhealth Care has appreciated by 3.36%, while the Sensex has declined by 2.26%. The stock’s one-year return of 33.38% far exceeds the Sensex’s 10.60%, and over three and five years, the gains have been even more pronounced at 73.74% and an impressive 399.50%, respectively, compared to the Sensex’s 39.74% and 67.42%. These figures highlight th..."
      },
      {
        "title": "Veerhealth Care Gains 5.31%: 3 Key Factors Driving the Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/veerhealth-care-gains-531-3-key-factors-driving-the-weekly-rally-3849815",
        "imagepath": "",
        "date": "2026-02-21 16:03:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Week opens at Rs.18.93 with positive momentum</p>\n                    <p><strong>17 Feb:</strong> Q3 FY26 results reveal strong revenue growth; Mojo Grade upgraded to Hold</p>\n                    <p><strong>18 Feb:</strong> Stock rallies 2.93% amid sustained buying interest</p>\n                    <p><strong>20 Feb:</strong> Week closes at Rs.19.82, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.18.82</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-valu..."
      },
      {
        "title": "Veerhealth Care Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-ltd-upgraded-to-hold-on-technical-and-financial-improvements-3843747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VeerhealthCareL_mojoScore_3843747.png",
        "date": "2026-02-17 08:28:05",
        "description": "Veerhealth Care Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements in its technical indicators and a reassessment of its valuation profile. Despite lingering concerns over fundamental financial metrics, the stock’s recent market performance and technical momentum have prompted analysts to revise their outlook, signalling cautious optimism for investors."
      },
      {
        "title": "Veerhealth Care Ltd Valuation Shifts Signal Price Attractiveness Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/veerhealth-care-ltd-valuation-shifts-signal-price-attractiveness-challenges-3843321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VeerhealthCareL_valuationdot_3843321.png",
        "date": "2026-02-17 08:02:26",
        "description": "Veerhealth Care Ltd has undergone a notable change in its valuation parameters, moving from a risky to a very expensive classification. This shift, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, warrants a closer examination of the stock’s price attractiveness relative to its historical performance and peer group within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Veerhealth Care Q3 FY26: Strong Revenue Surge Masks Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/veerhealth-care-q3-fy26-strong-revenue-surge-masks-profitability-concerns-3844235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VeerhealthCare_quaterlyResult_3844235.png",
        "date": "2026-02-16 23:56:25",
        "description": "Veerhealth Care Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹38.00 crores, reported a robust 89.06% year-on-year revenue surge in Q3 FY26, with net sales reaching ₹7.26 crores compared to ₹3.84 crores in the corresponding quarter last year. The company's net profit stood at ₹0.40 crores, marking a significant 471.43% year-on-year growth from ₹0.07 crores in Q3 FY25. However, the stock has been volatile, currently trading at ₹19.24, down 19.06% from its 52-week high of ₹23.77, though substantially above its 52-week low of ₹9.29."
      }
    ],
    "total": 155,
    "sid": "631680",
    "stock_news_url": "https://www.marketsmojo.com/news/veerhealth-care-631680"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "25-Feb-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Investors Presentation of the Company. The presentation is also being made available on the Companys Website www.veerhealthcare.net.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "25-Feb-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Investors Presentation of the Company. The presentation is also being made available on the Companys Website www.veerhealthcare.net.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "Extract of financial result published in newspaper is attached.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Veerhealth Care Ltd has announced <strong>10:1</strong> stock split, ex-date: 29 Nov 16",
          "dt": "2016-11-29",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Veerhealth Care Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 22 Sep 23",
          "dt": "2023-09-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Veerhealth Care Ltd is Rated Sell

2026-03-19 10:10:49

Veerhealth Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Veerhealth Care Ltd’s Mixed Week: -0.61% Price, Outperformance vs Sensex

2026-02-28 15:07:31

Key Events This Week

23 Feb 2026: Stock rises 0.81% to Rs.19.98, outperforming Sensex

25 Feb 2026: Death Cross formation signals potential bearish trend

26 Feb 2026: Mojo Grade downgraded to Sell amid mixed signals

27 Feb 2026: Stock closes week at Rs.19.70, down 1.35% on the day

Week Open

Rs.19.82

Week Close

Read full news article

Veerhealth Care Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-02-26 08:08:27

Veerhealth Care Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 February 2026. This shift reflects a complex interplay of factors across quality, valuation, financial trends, and technical indicators, despite the company’s recent positive quarterly performance and strong stock returns relative to benchmarks.

Read full news article

Veerhealth Care Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-02-25 18:50:16

Veerhealth Care Ltd (Stock ID: 631680) has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s near-term momentum and long-term strength within the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Veerhealth Care Ltd falling/rising?

2026-02-24 01:11:40

Consistent Outperformance Against Benchmarks

Veerhealth Care Ltd has demonstrated remarkable strength relative to the broader market, as evidenced by its performance compared to the Sensex. Over the past week, the stock surged by 5.55%, significantly outpacing the Sensex’s marginal gain of 0.02%. This trend extends over longer periods, with the stock delivering a 12.25% return in the last month against the Sensex’s 2.15%. Year-to-date, Veerhealth Care has appreciated by 3.36%, while the Sensex has declined by 2.26%. The stock’s one-year return of 33.38% far exceeds the Sensex’s 10.60%, and over three and five years, the gains have been even more pronounced at 73.74% and an impressive 399.50%, respectively, compared to the Sensex’s 39.74% and 67.42%. These figures highlight th...

Read full news article

Veerhealth Care Gains 5.31%: 3 Key Factors Driving the Weekly Rally

2026-02-21 16:03:03

Key Events This Week

16 Feb: Week opens at Rs.18.93 with positive momentum

17 Feb: Q3 FY26 results reveal strong revenue growth; Mojo Grade upgraded to Hold

18 Feb: Stock rallies 2.93% amid sustained buying interest

20 Feb: Week closes at Rs.19.82, outperforming Sensex

Week Open

Rs.18.82

Week Close

Read full news article

Veerhealth Care Ltd Upgraded to Hold on Technical and Financial Improvements

2026-02-17 08:28:05

Veerhealth Care Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements in its technical indicators and a reassessment of its valuation profile. Despite lingering concerns over fundamental financial metrics, the stock’s recent market performance and technical momentum have prompted analysts to revise their outlook, signalling cautious optimism for investors.

Read full news article

Veerhealth Care Ltd Valuation Shifts Signal Price Attractiveness Challenges

2026-02-17 08:02:26

Veerhealth Care Ltd has undergone a notable change in its valuation parameters, moving from a risky to a very expensive classification. This shift, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, warrants a closer examination of the stock’s price attractiveness relative to its historical performance and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

Veerhealth Care Q3 FY26: Strong Revenue Surge Masks Profitability Concerns

2026-02-16 23:56:25

Veerhealth Care Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹38.00 crores, reported a robust 89.06% year-on-year revenue surge in Q3 FY26, with net sales reaching ₹7.26 crores compared to ₹3.84 crores in the corresponding quarter last year. The company's net profit stood at ₹0.40 crores, marking a significant 471.43% year-on-year growth from ₹0.07 crores in Q3 FY25. However, the stock has been volatile, currently trading at ₹19.24, down 19.06% from its 52-week high of ₹23.77, though substantially above its 52-week low of ₹9.29.

Read full news article

View All News